88
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Secondary central nervous system lymphoma: spectrum of morphological MRI appearances

, , , , &
Pages 733-740 | Published online: 12 Mar 2018

References

  • HaiounCBessonCLepageEIncidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d’Etudes des Lymphomes de l’AdulteAnn Oncol200011668569010942056
  • JahnkeKThielEMartusPSchwartzSKorfelARetrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous systemAnn Hematol2006851455016132909
  • BernsteinSHUngerJMLeblancMFriedbergJMillerTPFisherRINatural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516 – the Southwest Oncology GroupJ Clin Oncol200927111411919047289
  • VillaDConnorsJMShenkierTNGascoyneRDSehnLHSavageKJIncidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapyAnn Oncol20102151046105219861575
  • BiermanPGiglioPDiagnosis and treatment of central nervous system involvement in non-Hodgkin’s lymphomaHematol Oncol Clin North Am200519459760916083825
  • GrimmSChamberlainMHodgkin’s lymphoma: a review of neurologic complicationsAdv Hematol2011201162457820975772
  • HaldorsenISEspelandALarssonE-MCentral nervous system lymphoma: characteristic findings on traditional and advanced imagingAm J Neuroradiol201132698499220616176
  • HillQAOwenRGCNS prophylaxis in lymphoma: who to target and what therapy to useBlood Rev200620631933216884838
  • KeldsenNMichalskiWBentzenSMHansenKBThorlingKRisk factor for central nervous system involvement in non-Hodgkins-lymphoma – a multivariable analysisActa Oncol19963567037088938217
  • van BesienKHaCSMurphySRisk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphomaBlood1998914117811849454747
  • ZinzaniPLMagagnoliMFerezzaGIsolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experienceLeuk Lymphoma1999325–657157610048430
  • HollenderAKvaloySNomeOSkovlundELoteKHolteHCentral nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk modelAnn Oncol20021371099110712176790
  • PittmanMTreeseSChenLUtility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphomaArch Pathol Lab Med2013137111610161824168498
  • BhagavathiSWilsonJDPrimary central nervous system lymphomaArch Pathol Lab Med2008132111830183418976024
  • KoubskaEWeichetJMalikovaHCentral nervous system lymphoma: a morphological MRI studyNeuro Endocrinol Lett201637431832427857050
  • Hernández RubioLGiner BernabeuJCPerez SempereAToroPPrimary cerebral lymphoma with spontaneous remissionNeurologia201328212312622037213
  • MalikovaHKoubskaEWeichetJCan morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?Cancer Imaging20161614027894359
  • HaldorsenISKråkenesJKrossnessBKMellaOEspelandACT and MR imaging features of primary central nervous system lymphoma in Norway, 1989–2003Am J Neuroradiol200930474475119164442
  • SenocakEOguzKKOzgenBParenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphomaEur J Radiol201179228829420202775
  • MalikovaHLiscakRLatnerovaIComplications of MRI-guided stereotactic biopsy of brain lymphomaNeuro Endocrinol Lett201435761361825617885